Logo image
Se connecter
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Article de revue   Avec comité de lecture

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Christina Nowack, Peter Kolkhof, Amer Joseph, Nicole Mentenich, Bertram Pitt, …
2019

Résumé

Aldosterone ANTAGONIST BAY 94-8862 CHRONIC HEART-FAILURE Clinical COMPLICATIONS Diabetes EFFICACY Kidney Medicine and Health Sciences MILD MINERALOCORTICOID Outcomes RECEPTOR RISK SPIRONOLACTONE WORSENING RENAL-FUNCTION

Indicateurs

1 Consultations de la notice

Détails

Logo image